Latest News about MRNA
Recent news which mentions MRNA
3 Healthcare Stocks to Invest in for a Big Shot of Gains
October 23, 2023
From InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $100
October 23, 2023
From Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?
October 22, 2023
From Motley Fool
From MarketWatch
Why Moderna Stock Is Sinking This Week
October 19, 2023
From Motley Fool
3 Stocks That Are Dead in the Water
October 19, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
From Benzinga
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
October 19, 2023
From Motley Fool
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
October 17, 2023
From Benzinga
What's Going On With Moderna Stock?
October 17, 2023
From Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
From Motley Fool
From MarketWatch
From MarketWatch
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
From Benzinga
Is Novavax Stock a Buy Now?
October 16, 2023
From Motley Fool
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
October 16, 2023
From MarketWatch
Don’t Hold On: 7 Stocks to Sell Before 2024
October 15, 2023
From InvestorPlace
Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments
October 13, 2023
From MarketWatch
From Motley Fool
2 Top Biotech Stocks to Buy Right Now
October 12, 2023
From Motley Fool
3 Stocks That Are Down Big, But Are Due to Fall Much Further
October 12, 2023
From InvestorPlace
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
From Motley Fool
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
From Benzinga
3 Shaky Stocks to Sell in October Before It’s Too Late
October 09, 2023
From InvestorPlace
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free